Status:
COMPLETED
Characterization of the Genetic Profile of Type 2 Endometrial Carcinoma in Martinique
Lead Sponsor:
University Hospital Center of Martinique
Collaborating Sponsors:
Martinique Cancer Registry
Conditions:
Endometrial Neoplasms
Eligibility:
FEMALE
Brief Summary
In Martinique, about 33 new cases are diagnosed per year, with a high incidence rate of type 2 endometrial carcinoma which has a poor prognosis with few therapeutic options. Although targeted therapie...
Detailed Description
Type 2 endometrial carcinomas are often diagnosed at advanced stages, with an high risk of metastatic recurrence and death even when diagnosed at early stages. They also have few therapeutic options. ...
Eligibility Criteria
Inclusion
- Major subject living in Martinique with the following characteristics :
- Patients with type 2 endometrial cancer, with anatomopathological confirmation
- Affiliate or beneficiary of french social security.
- Free, informed with a written consent signed by the participant and the investigator (at the latest on the day of inclusion and before any research required by the research).
Exclusion
- Type 1 adenocarcinoma
- Patients not affiliated to french social security
- Refusal to participate.
Key Trial Info
Start Date :
November 22 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 22 2024
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03766672
Start Date
November 22 2019
End Date
July 22 2024
Last Update
August 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Martinique
Fort-de-France, Martinique